Bioleaders Corp. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1,318
6,346
5,978
15,401
25,884
Total Accounts Receivable
376
572
781
1,290
3,586
Inventories
619
944
981
543
1,189
Other Current Assets
104
113
161
436
248
Total Current Assets
2,417
7,974
7,902
17,671
30,907
Net Property, Plant & Equipment
5,567
369
469
1,459
3,893
Total Investments and Advances
43
551
55
43
786
Long-Term Note Receivable
-
-
37
862
799
Intangible Assets
1,975
1,644
700
813
514
Other Assets
82
369
376
765
678
Total Assets
10,084
10,907
9,540
21,613
37,576
ST Debt & Current Portion LT Debt
3,610
705
705
-
-
Accounts Payable
15
17
7
14
434
Other Current Liabilities
2,397
1,622
2,741
3,184
1,509
Total Current Liabilities
6,022
2,344
3,453
3,198
1,943
Long-Term Debt
1,171
1,402
-
-
-
Provision for Risks & Charges
108
103
-
95
269
Other Liabilities
848
848
67
342
171
Total Liabilities
8,149
4,697
3,520
3,635
2,383
Common Equity (Total)
558
3,859
5,553
17,462
35,165
Total Shareholders' Equity
1,158
5,459
5,553
17,462
35,165
Total Equity
1,158
5,459
5,553
17,462
35,193
Liabilities & Shareholders' Equity
10,084
10,907
9,540
21,613
37,576
Accumulated Minority Interest
-
-
-
-
27
Non-Equity Reserves
777
751
467
515
-
Preferred Stock (Carrying Value)
600
1,600
-
-
-

About Bioleaders

View Profile
Address
13 Techno 8-ro
Daejeon DE 34028
Korea, Republic Of
Employees -
Website http://www.bioleaders.co.kr
Updated 09/14/2018
Bioleaders Corp. is a holding company, which engages in the development of biopharmaceutical products. It operates through following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products.